KANE: Racist thoughts still tinge Black Expo
It has been unfortunate to hear the criticisms and judgmental rumblings regarding the decorum of expo visitors and tourists over the past few years.
Home » Search
Search Results
4,602 results for 'mental health'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
Rising use of part-time faculty sparks worries
Some advocacy groups argue that an overreliance on part-time faculty can weaken the academic experience for students on campus.
Public safety due for budget cuts, mayor says
Public safety and criminal justice are the only places left in the city-county budgets to look for ways to close a $27 million spending gap for 2013. Sheriff, police, fire and court budgets account for 85 percent of the $569 million general fund.
Life Sciences Power Breakfast – transcript
Life sciences leaders discuss topics ranging from accomplishments to initial public offerings and the nature of innovation at the July 25 event.
Indiana life sciences companies rethink innovation
Research and development comes under pressure in an age of austerity.
Lilly’s quarterly profit falls, but tops analyst expectations
Eli Lilly and Co. reported second-quarter profit that fell less than analysts had expected. The company raised its outlook for the rest of the year.
Company news
Indiana University has received the go-ahead to begin the accreditation process for new schools of public health proposed for its Bloomington and Indianapolis campuses, according to the Associated Press. University officials said the step by the independent Council on Education for Public Health kicks off an expected two-year process to create schools of public health on IU's two largest campuses. The school on the Bloomington campus will focus on rural communities. The Indianapolis school will focus on urban health and health policy, as well as on collaborative work with the IU School of Medicine.
An antipsychotic drug that Eli Lilly and Co. hoped would be an improved replacement for Zyprexa failed in a late-stage study that compared patients taking the drug to those taking a placebo. The drug, known as pomaglumetad methionil, or mGlu 2/3, showed no difference versus a placebo. A control group of patients taking another drug, risperidone, which goes by the brand name Risperdal, did show a difference. Despite the failure, Lilly said it would continue to conduct two other clinical trials of the drug. Lilly is studying pomaglumetad methionil to see whether it can work as an antipsychotic without side effects like weight gain that come with current treatments. Zyprexa, which reached peak annual sales of $5 billion, lost its U.S. and European patent protection last fall.
A chain of dental offices that abruptly closed multiple Indiana locations in December 2010 left patients without care, refunds or records, according to a complaint filed by the Office of the Indiana Attorney General. Attorney General Greg Zoeller has filed a complaint against Allcare Dental & Dentures, which closed offices in Anderson, Avon, Evansville, Fort Wayne, Indianapolis, Mishawaka and Muncie. The complaint alleges multiple licensing violations against company President Robert Bates. The complaint says Allcare failed to reimburse patients who paid upfront for services that weren’t completed; failed to complete dental procedures in progress; didn’t provide dentures that were fabricated; and locked dentists out of their offices, rendering them unable to notify patients or transfer patient records as the law requires. Massachusetts, New Hampshire, North Dakota, Ohio and West Virginia also have taken actions against Bates’ dental licenses for similar violations. Bates has settled or been party to consent agreements with licensing boards of each of those states, according to the AG’s complaint. The Indiana State Board of Dentistry is scheduled to conduct a hearing on the complaint Oct. 5.
After six months of denying coverage for a $350 genetic test for each of three Indiana children, Indianapolis-based WellPoint Inc. reversed itself and will now pay for the tests, according to Bloomberg News. The father of the three children, Matthew Christman, has an inherited heart disease that often strikes without warning. Since December, WellPoint’s Anthem Blue Cross and Blue Shield unit had denied paying for the test, saying it was “experimental” and “not medically necessary,” according to Bloomberg. The test is made by New Jersey-based Bio-Reference Labs Inc.
Lilly gets boost in Alzheimer’s race
Eli Lilly and Co. got a boost of confidence last week that its project to launch the first effective Alzheimer’s treatment is on the right track—though it still faces hugely long odds.
WellPoint agrees to pay for 3 children to get gene test
WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
Competing Alzheimer’s treatments facing long odds
Johnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available drug designed to target a cause of Alzheimer’s, rather than just its symptoms. Analysts say the potential drugs are long shots.
TAFT: Institutions must invest in neighborhoods
Local government should encourage such partnerships.
KRULL: Something for everyone in the health care ruling
The Supreme Court will have to revisit this issue again—and perhaps more decisively.
SWAYZE: Voters ready to retrieve turf from the left
Most in the political industry are continuing old-school tactics.
MAURER: Daniels can lead beyond Purdue
I wonder what President Daniels can do off campus to benefit the nation and the world from the platform he has been presented.
Drought brings added challenges for not-for-profit farms
The parched conditions have forced staff and volunteers at dozens of not-for-profit farms and community gardens to struggle with problems as basic as finding water.
Company news
Covance Inc. is seeking state and local tax incentives as part of a $150 million expansion that would create 465 jobs at its Greenfield operations, nearly doubling the number of employees there. The proposed expansion would occur over the next four years and include the construction of a new laboratory, the renovation of existing buildings, and the hiring of administrative and laboratory personnel, according to the Daily Reporter in Greenfield. Princeton, N.J.-based Covance, a pharmaceutical research company, acquired Greenfield Labs from Eli Lilly and Co. in October 2008 for $50 million and a 10-year agreement from Lilly to use Covance’s services. At that time, 264 Lilly employees shifted to Covance. The company now employs 565 workers at the site, according to the newspaper. The Hancock County Council is set to hear Covance’s request for incentives July 11. Documents filed with the county show the 465 jobs would add $29 million in salaries with annual pay averaging more than $62,000 per employee, the Daily Reporter said. The company uses the Greenfield Laboratories to conduct early-stage tests of experimental drug molecules, readying them for tests in humans.
Officials from Indiana University Health Arnett broke ground on a facility in West Lafayette last week, according to the Journal and Courier of Lafayette. The new location, housed in a former Kmart store, will add outpatient imaging and expanded laboratory services to IU Health’s existing services in West Lafayette. The $8 million facility also will include an urgent care center with extended hours of operation. Indianapolis-based IU Health operates a full-scale hospital in Lafayette.
Dr. Yang Sun, an assistant professor of ophthalmology at the Glick Eye Institute, received a five-year, $1 million grant from the National Eye Institute to study congenital glaucoma with the hope of discovering new treatments for common forms of glaucoma. “Glaucoma is a leading cause of irreversible blindness in the world, yet the mechanisms of glaucoma development remain poorly understood, and treatments are limited,” Sun said. “I’m hoping to understand the mechanism of inherited congenital glaucoma, in the hopes that this will provide insight and potentially lead to novel treatments for commonly seen forms of glaucoma.”
MORRIS: Let’s celebrate—and work—together
We need to fight the urge to be so unyielding and negative much of the time.
Indiana child services agency increasing spending
The Indiana Department of Child Services expects to serve more than 11,000 additional families each year by adding a total of $47.8 million over three years to new and existing programs.